Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
0.6051
+0.0024 (0.40%)
At close: Sep 17, 2025, 4:00 PM EDT
0.6011
-0.0040 (-0.66%)
Pre-market: Sep 18, 2025, 9:11 AM EDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $5.24 million as of September 18, 2025. Its market cap has decreased by -59.96% in one year.
Market Cap
5.24M
Enterprise Value
-571.77K
1-Year Change
-59.96%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $5.24M, an increase of 5.46%. That is a compound annual growth rate of 0.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 5.24M | -52.67% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | 67.08M | 364.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.53B |
| Johnson & Johnson | 427.22B |
| AbbVie | 379.28B |
| UnitedHealth Group | 315.64B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 230.16B |